Asian patients with hepatitis C (HCV) genotype 1 treated with ledipasvir and sofosbuvir (LDV/SOF) experience very high efficacy and improvement of health-related quality of life (HRQL)

Zobair Younossi, Maria Stepanova, Kwang-Hyub Han, Young-Suk Lim, Youn-Jae Lee, Wan-Long Chuang, Jia-Horng Kao, Rong-Nan Chien, Ting-Tsung Chang, Cheng-Yuan Peng

Research output: Contribution to journalJournal Article peer-review

Original languageAmerican English
Pages (from-to)376-376
JournalJournal of Gastroenterology and Hepatology
StatePublished - 2016

Cite this